# Lack of association between polymorphisms in STK39, a putative thiazide response gene, and blood pressure response to hydrochlorothiazide

## Metadata
**Authors:** Julio D Duarte, Maximilian T Lobmeyer, Zhiying Wang, Arlene B Chapman, John G Gums, Taimour Y Langaee, Eric Boerwinkle, Stephen T Turner, Julie A Johnson
**Journal:** Pharmacogenetics and genomics
**Date:** 2010 Aug
**DOI:** [10.1097/FPC.0b013e32833b5958](https://doi.org/10.1097/FPC.0b013e32833b5958)
**PMID:** 20555294
**PMCID:** PMC2922977
**URL:** https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922977/
**PDF:** [https://pmc.ncbi.nlm.nih.gov/articles/PMC2922977/pdf/nihms-214380.pdf](https://pmc.ncbi.nlm.nih.gov/articles/PMC2922977/pdf/nihms-214380.pdf)

## Abstract

STK39 was previously implicated as a hypertension susceptibility gene and is thought to be involved in control of Na+-Cl− cotransporter (NCC) activity. STK39 has been implicated as a putative thiazide diuretic response gene, as NCC activity is inhibited by thiazides. Thus, we aimed to determine whether STK39 is a thiazide response gene. 195 “good” and 194 “poor” responders to hydrochlorothiazide (HCTZ) were genotyped for approximately 100 single nucleotide polymorphisms (SNPs) within 5000 bases of STK39. SNPs meeting criteria for advancement to replication analysis (P<0.01), along with those previously associated with hypertension, were then analyzed in a second population of 201 HCTZ-treated hypertensives. Two SNPs met these criteria and were analyzed for replication. However, neither these, nor previously implicated SNPs significantly associated with blood pressure response to HCTZ. These data suggest common variants in STK39 likely do not have a clinically relevant role in blood pressure response to HCTZ in hypertensives.

Keywords: STK39, SPAK, hypertension, diuretics, hydrochlorothiazide, blood pressure, pharmacogenetics, thiazides, single nucleotide polymorphisms

## Supplementary Material

## ACKNOWLEDGEMENTS

For GERA: We are thankful for the technical assistance of Meagan Grove, Jodie Van De Rostyne, Jeremy Palbicki, Robert Tarrell, and Prabin Thapa.

For PEAR: We acknowledge and thank the valuable contributions of the study participants, support staff, and study physicians: Drs. George Baramidze, Carmen Bray, Kendall Campbell, R. Whit Curry, Karen Hall, Frederic Rabari-Oskoui, Dan Rubin, and Siegfried Schmidt.

**SOURCES OF SUPPORT:** GERA: This work was supported by NIH grants HL 74735, HL 53335, and the Mayo Foundation. PEAR: This work is supported by a grant from the National Institutes of Health (Bethesda, MD), grant U01 GM074492, funded as part of the Pharmacogenetics Research Network. This work is also supported by the following grants from the NIH National Center for Research Resources: grant M01 RR00082 and UL1 RR029890 to the University of Florida, grants UL1 RR025008 and M01 RR00039 to Emory University, and UL1 RR024150 to Mayo Clinic. J.D.D. is supported by NIH grant T32 DK007518.

## Footnotes

## Associated Data

*This section collects any data citations, data availability statements, or supplementary materials included in this article.*

### Supplementary Materials

### Supplementary Materials

## References

1. Richardson C, Rafiqi FH, Karlsson HK, Moleleki N, Vandewalle A, Campbell DG, et al. Activation of the thiazide-sensitive Na+-Cl− cotransporter by the WNK-regulated kinases SPAK and OSR1. J Cell Sci. 2008;121:675–84. doi: 10.1242/jcs.025312.  [DOI](https://doi.org/10.1242/jcs.025312) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/18270262/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J%20Cell%20Sci&title=Activation%20of%20the%20thiazide-sensitive%20Na+-Cl%E2%88%92%20cotransporter%20by%20the%20WNK-regulated%20kinases%20SPAK%20and%20OSR1&author=C%20Richardson&author=FH%20Rafiqi&author=HK%20Karlsson&author=N%20Moleleki&author=A%20Vandewalle&volume=121&publication_year=2008&pages=675-84&pmid=18270262&doi=10.1242/jcs.025312&)

2. Moriguchi T, Urushiyama S, Hisamoto N, Iemura S, Uchida S, Natsume T, et al. WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1. J Biol Chem. 2005;280:42685–93. doi: 10.1074/jbc.M510042200.  [DOI](https://doi.org/10.1074/jbc.M510042200) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/16263722/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J%20Biol%20Chem&title=WNK1%20regulates%20phosphorylation%20of%20cation-chloride-coupled%20cotransporters%20via%20the%20STE20-related%20kinases,%20SPAK%20and%20OSR1&author=T%20Moriguchi&author=S%20Urushiyama&author=N%20Hisamoto&author=S%20Iemura&author=S%20Uchida&volume=280&publication_year=2005&pages=42685-93&pmid=16263722&doi=10.1074/jbc.M510042200&)

3. Kahle KT, Ring AM, Lifton RP. Molecular physiology of the WNK kinases. Annu Rev Physiol. 2008;70:329–55. doi: 10.1146/annurev.physiol.70.113006.100651.  [DOI](https://doi.org/10.1146/annurev.physiol.70.113006.100651) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/17961084/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Annu%20Rev%20Physiol&title=Molecular%20physiology%20of%20the%20WNK%20kinases&author=KT%20Kahle&author=AM%20Ring&author=RP%20Lifton&volume=70&publication_year=2008&pages=329-55&pmid=17961084&doi=10.1146/annurev.physiol.70.113006.100651&)

4. Wang Y, O’Connell JR, McArdle PF, Wade JB, Dorff SE, Shah SJ, et al. From the Cover: Whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci U S A. 2009;106:226–31. doi: 10.1073/pnas.0808358106.  [DOI](https://doi.org/10.1073/pnas.0808358106) | [PMC free article](/articles/PMC2629209/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/19114657/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&title=From%20the%20Cover:%20Whole-genome%20association%20study%20identifies%20STK39%20as%20a%20hypertension%20susceptibility%20gene&author=Y%20Wang&author=JR%20O%E2%80%99Connell&author=PF%20McArdle&author=JB%20Wade&author=SE%20Dorff&volume=106&publication_year=2009&pages=226-31&pmid=19114657&doi=10.1073/pnas.0808358106&)

5. Turner ST, Schwartz GL, Chapman AB, Boerwinkle E. WNK1 kinase polymorphism and blood pressure response to a thiazide diuretic. Hypertension. 2005;46:758–65. doi: 10.1161/01.HYP.0000186240.81996.57.  [DOI](https://doi.org/10.1161/01.HYP.0000186240.81996.57) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/16172412/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Hypertension&title=WNK1%20kinase%20polymorphism%20and%20blood%20pressure%20response%20to%20a%20thiazide%20diuretic&author=ST%20Turner&author=GL%20Schwartz&author=AB%20Chapman&author=E%20Boerwinkle&volume=46&publication_year=2005&pages=758-65&pmid=16172412&doi=10.1161/01.HYP.0000186240.81996.57&)

6. Chapman AB, Schwartz GL, Boerwinkle E, Turner ST. Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension. Kidney Int. 2002;61:1047–55. doi: 10.1046/j.1523-1755.2002.00200.x.  [DOI](https://doi.org/10.1046/j.1523-1755.2002.00200.x) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/11849460/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Kidney%20Int&title=Predictors%20of%20antihypertensive%20response%20to%20a%20standard%20dose%20of%20hydrochlorothiazide%20for%20essential%20hypertension&author=AB%20Chapman&author=GL%20Schwartz&author=E%20Boerwinkle&author=ST%20Turner&volume=61&publication_year=2002&pages=1047-55&pmid=11849460&doi=10.1046/j.1523-1755.2002.00200.x&)

7. Johnson JA, Boerwinkle E, Zineh I, Chapman AB, Bailey K, Cooper-DeHoff RM, et al. Pharmacogenomics of antihypertensive drugs: rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study. Am Heart J. 2009;157:442–9. doi: 10.1016/j.ahj.2008.11.018.  [DOI](https://doi.org/10.1016/j.ahj.2008.11.018) | [PMC free article](/articles/PMC2671287/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/19249413/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am%20Heart%20J&title=Pharmacogenomics%20of%20antihypertensive%20drugs:%20rationale%20and%20design%20of%20the%20Pharmacogenomic%20Evaluation%20of%20Antihypertensive%20Responses%20(PEAR)%20study&author=JA%20Johnson&author=E%20Boerwinkle&author=I%20Zineh&author=AB%20Chapman&author=K%20Bailey&volume=157&publication_year=2009&pages=442-9&pmid=19249413&doi=10.1016/j.ahj.2008.11.018&)

8. Turner ST, Bailey KR, Fridley BL, Chapman AB, Schwartz GL, Chai HS, et al. Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic. Hypertension. 2008;52:359–65. doi: 10.1161/HYPERTENSIONAHA.107.104273.  [DOI](https://doi.org/10.1161/HYPERTENSIONAHA.107.104273) | [PMC free article](/articles/PMC2692710/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/18591461/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Hypertension&title=Genomic%20association%20analysis%20suggests%20chromosome%2012%20locus%20influencing%20antihypertensive%20response%20to%20thiazide%20diuretic&author=ST%20Turner&author=KR%20Bailey&author=BL%20Fridley&author=AB%20Chapman&author=GL%20Schwartz&volume=52&publication_year=2008&pages=359-65&pmid=18591461&doi=10.1161/HYPERTENSIONAHA.107.104273&)

9. Keating BJ, Tischfield S, Murray SS, Bhangale T, Price TS, Glessner JT, et al. Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for largescale genomic association studies. PLoS ONE. 2008;3:e3583. doi: 10.1371/journal.pone.0003583.  [DOI](https://doi.org/10.1371/journal.pone.0003583) | [PMC free article](/articles/PMC2571995/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/18974833/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=PLoS%20ONE&title=Concept,%20design%20and%20implementation%20of%20a%20cardiovascular%20gene-centric%2050%20k%20SNP%20array%20for%20largescale%20genomic%20association%20studies&author=BJ%20Keating&author=S%20Tischfield&author=SS%20Murray&author=T%20Bhangale&author=TS%20Price&volume=3&publication_year=2008&pages=e3583&pmid=18974833&doi=10.1371/journal.pone.0003583&)

10. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR, et al. A common allele on chromosome 9 associated with coronary heart disease. Science. 2007;316:1488–91. doi: 10.1126/science.1142447.  [DOI](https://doi.org/10.1126/science.1142447) | [PMC free article](/articles/PMC2711874/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/17478681/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Science&title=A%20common%20allele%20on%20chromosome%209%20associated%20with%20coronary%20heart%20disease&author=R%20McPherson&author=A%20Pertsemlidis&author=N%20Kavaslar&author=A%20Stewart&author=R%20Roberts&volume=316&publication_year=2007&pages=1488-91&pmid=17478681&doi=10.1126/science.1142447&)
